CORONAVIRUS/COVID-19 vaccine candidate shows promising results in early testing

05/06/2020 04:42 PM
To activate the text-to-speech service, please first agree to the privacy policy below.

Taipei, May 6 (CNA) Taiwan's Adimmune Corporation said Wednesday that it has developed a COVID-19 vaccine candidate that has shown promising results in tests on lab rodents, and that it plans to begin human trials in the second half of this year.


(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)

View All
We value your privacy.
Focus Taiwan (CNA) uses tracking technologies to provide better reading experiences, but it also respects readers' privacy. Click here to find out more about Focus Taiwan's privacy policy. When you close this window, it means you agree with this policy.